Target intelligence / Profile preview

Retinal ganglion cell (RGC)

Target
RGC
Molecular classification
Other (neuronal cell type), not a single molecule/receptor, neuron
01

Overview

**Retinal ganglion cells (RGCs)** are a type of neuron located in the ganglion cell layer of the retina and are the final output neurons connecting the retina to the brain[1][3][5][7]. Each RGC receives synaptic input from bipolar and amacrine cells that have integrated signals from photoreceptors (rods and cones)[1][3][7]. RGCs generate action potentials and transmit visual information via the optic nerve to multiple visual centers in the brain, including the lateral geniculate nucleus and the superior colliculus[1][3]. They are highly diverse, with at least 20–40 subtypes in mammals, differing in morphology, physiology, gene expression, and functional specialization for aspects such as color, motion, and contrast[3][5][6]. Subtypes include midget, parasol, and bistratified cells, as well as intrinsically photosensitive RGCs (ipRGCs), which express melanopsin and directly sense light for non-image-forming functions[3][4][5]. RGC loss is the key pathological event in glaucoma and other optic neuropathies[3][5]. While RGCs are critical in disease biology and may represent a therapeutic target cell population, they are not themselves a canonical pharmacological target such as a receptor, ion channel, or enzyme. **Note:** - There is something intrinsically incorrect about listing "Retinal ganglion cell" as a therapeutic target in the conventional molecular or drug discovery sense, as it is a heterogeneous cell population—not a single molecule, receptor, channel, or enzyme. - Therapeutic interventions may aim to protect, replace, or stimulate these cells, but drugs do not act *on* "retinal ganglion cell" as a target in the classical sense. Instead, treatments may modulate pathways within or protective factors for these neurons[3][5]. - Whenever possible, drug targeting should be specified at the molecular/protein/receptor level within RGCs (e.g., melanopsin/OPN4, neurotrophic receptor, etc.). References: See entries [1], [3], [5], [7] for the most comprehensive overview.

Other names
Ganglion cell (retinal)RGCretinal output neuronoptic nerve ganglion cell
02

Mechanism of action

Not applicable for drugs (see above)

03

Biological functions

Visual signal transmissionAction potential generationSignal integrationAxonal projection to brain visual centersImage-forming and non-image visual signaling
04

Disease associations

Neurodegenerative disease (notably glaucoma)Optic neuropathiesHereditary retinal degenerations
05

Safety considerations

None specific (cell loss underlies vision loss in disease; transplantation, gene therapy, and neuroprotection carry standard risks for central nervous system interventions)
06

Interacting drugs

None (drugs do not directly target RGC as a molecule; neuroprotective agents, growth factors, and gene therapies may aim to preserve or restore RGC function in disease, but RGC is a cell type, not a direct molecular target)
07

Biomarkers

RGC count (imaging, histology)retinal nerve fiber layer thickness (OCT)pattern electroretinographyOPN4 (melanopsin for ipRGC subtypes)RBPMS (marker of RGCs in primates)

Beyond the preview

Go deeper on Retinal ganglion cell (RGC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinal ganglion cell (RGC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call